Polyoxymethylene (POM) in the Production of Telescopic Denture in Older Adults With Subtotal Edentulism
Launched by UNIVERSITY OF BELGRADE · Sep 9, 2024
Trial Information
Current as of June 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of a new type of removable partial denture made from a material called polyoxymethylene (POM) for older adults who have lost some teeth, a condition known as subtotal edentulism. The goal is to see if this POM denture is just as effective, safe, and comfortable as traditional dentures made from more expensive metals. Since many older adults need dental care, finding a simple and cost-effective solution is very important. The trial will look at how well the dentures stay in place, how they affect oral health and quality of life, and whether there are any problems with the dentures over time.
To be eligible for this study, participants need to be 65 years or older and have some remaining teeth that are healthy enough to support the denture. People with certain dental issues, like severe jaw problems or unhealthy teeth, won't be able to join the trial. If you decide to participate, you can expect to have your dentures assessed for comfort and function, and your overall oral health will be monitored throughout the study. This trial aims to provide valuable information that could improve denture options for older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients aged 65 and over
- • patients with subtotal edentulism
- • patients who sign an informed consent for participation in the study
- • retention teeth must have a minimum crown/root ratio of 1:1
- • retention teeth must have sufficient tooth substance (at least two walls)
- Exclusion Criteria:
- • patients younger than 65 years
- • patients with temporomandibular joint dysfunction
- • patiens with bruxism
- • presence of intrabony defects around the retention teeth
- • presence of pathological tooth mobility
- • presence of periapical inflammatory processes, abscesses and fistulas in the region of retention teeth
- • presence of fetor and suppuration from periodontal pockets of retention teeth
About University Of Belgrade
The University of Belgrade, a leading institution in the field of higher education and research in Serbia, is committed to advancing medical science through rigorous clinical trials. With a focus on innovation and collaboration, the university leverages its diverse expertise to conduct research that addresses critical health challenges. By integrating cutting-edge methodologies and fostering partnerships with healthcare professionals and organizations, the University of Belgrade aims to contribute valuable insights into disease prevention, treatment efficacy, and improved patient outcomes, thereby enhancing the overall quality of care in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belgrade, , Serbia
Patients applied
Trial Officials
Aleksandra Popovac
Study Chair
School of Dental Medicine, University of Belgrade
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported